Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site

被引:97
|
作者
Durdagi, Serdar [2 ]
Senturk, Murat [1 ]
Ekinci, Deniz [3 ,4 ]
Balaydin, Halis Turker [5 ]
Goksu, Suleyman [6 ]
Kufrevioglu, O. Irfan [6 ]
Innocenti, Alessio [7 ]
Scozzafava, Andrea [7 ]
Supuran, Claudiu T. [7 ]
机构
[1] Ibrahim Cecen Univ Agri, Sci & Art Fac, Dept Chem, TR-04100 Agri, Turkey
[2] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada
[3] Ondokuz Mayis Univ, Fac Agr, Dept Agr Biotechnol, TR-55139 Samsun, Turkey
[4] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
[5] Artvin Coruh Univ, Fac Educ, TR-08100 Artvin, Turkey
[6] Ataturk Univ, Fac Sci, Dept Chem, TR-25240 Erzurum, Turkey
[7] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
关键词
Carbonic anhydrase; Phenol; Sulfonamide; Dimethoxy-benzene; Phenolic acid; Docking; Enzyme inhibition; ISOZYME-II; CRYSTAL-STRUCTURE; SALICYLIC-ACID; ACTIVATORS; SULFONAMIDES; COUMARINS; DESIGN; AGENTS; ADDUCT; SERIES;
D O I
10.1016/j.bmc.2011.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1381 / 1389
页数:9
相关论文
共 49 条
  • [1] Inhibition Studies on Carbonic Anhydrase Isoforms I, II, IX, and XII with a Series of Sulfaguanidines
    Abdoli, Morteza
    De Luca, Viviana
    Capasso, Clemente
    Supuran, Claudiu T.
    Zalubovskis, Raivis
    CHEMMEDCHEM, 2023, 18 (06)
  • [2] Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII
    Khloya, Poonam
    Ceruso, Mariangela
    Ram, Sita
    Supuran, Claudiu T.
    Sharma, Pawan K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (16) : 3208 - 3212
  • [3] Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors
    Angapelly, Srinivas
    Ramya, P. V. Sri
    Angeli, Andrea
    Del Prete, Sonia
    Capasso, Clemente
    Arifuddin, Mohammed
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5726 - 5732
  • [4] Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors
    Ramya, P. V. Sri
    Angapelly, Srinivas
    Angeli, Andrea
    Digwal, Chander Singh
    Arifuddin, Mohammed
    Babu, Bathini Nagendra
    Supuran, Claudiu T.
    Kamal, Ahmed
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 1274 - 1281
  • [5] Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: A new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies
    Chazalette, C
    Riviere-Baudet, M
    Scozzafava, A
    Abbate, F
    Ben Maarouf, Z
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION, 2001, 16 (02): : 125 - +
  • [6] Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II
    Salmas, Ramin Ekhteiari
    Mestanoglu, Mert
    Durdagi, Serdar
    Senturk, Murat
    Kaya, A. Afsin
    Kaya, Elif Celenk
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (01) : 31 - 37
  • [7] New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII
    Meleddu, Rita
    Distinto, Simona
    Cottiglia, Filippo
    Angius, Rossella
    Caboni, Pierluigi
    Angeli, Andrea
    Melis, Claudia
    Deplano, Serenella
    Alcaro, Stefano
    Ortuso, Francesco
    Supuran, Claudiu T.
    Maccioni, Elias
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (05): : 852 - 856
  • [8] Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV
    Carta, Fabrizio
    Vullo, Daniela
    Maresca, Alfonso
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1564 - 1569
  • [9] Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties
    Ghorab, Mostafa M.
    Alsaid, Mansour S.
    Ceruso, Mariangela
    Nissan, Yassin M.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (14) : 3684 - 3695
  • [10] Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
    Milite, Ciro
    Amendola, Giorgio
    Nocentini, Alessio
    Bua, Silvia
    Cipriano, Alessandra
    Barresi, Elisabetta
    Feoli, Alessandra
    Novellino, Ettore
    Da Settimo, Federico
    Supuran, Claudiu T.
    Castellano, Sabrina
    Cosconati, Sandro
    Taliani, Sabrina
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1697 - 1710